DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Osawa M, Imamura M, Teraoka Y. , et al; Hiroshima Liver Study Group.
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
J Gastroenterol 2019;
54 (03) 291-296
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.